Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Comment by 4evergreenon Oct 12, 2017 11:24pm
65 Views
Post# 26807966

RE:RE:RE:RE:Aphria buying Tetra is pure speculation...

RE:RE:RE:RE:Aphria buying Tetra is pure speculation...

News forthcoming in the coming weeks on Phase 3 clinal trial (big NR), sales commencing (big NR), international distribution parther announcement (big NR), presenting at prestigious BIO investor conferences, new potential partners/buyout possibilities, and the list goes on...

LeafRider wrote:

I expect solid news coming out prior to end of October, and I can't see Tetra holding it back either. It's going to be one thing after another. Commencing phase 3 clinical, issuing a statement related to sales commencing for the quarter, also naming the distribution partner for our OTC product line, and quite possibly other partnerships and distribution type news is waiting in the wings. These things we know are on the near horizon. There are many other possibilities out there as far as news goes, we have a few items in the pipeline which I would like to think will eventually be successful in their phase 1 clinicals. If these are successful and they move forward, our share price will have no choice but to rise.

For me when I see sales and distribution, that tells me that we are on the verge of sales growth, which will be a catalyst for SP growth. If an institutional buyer gets on board with Tetra, you're going to see a big upswing as well.




<< Previous
Bullboard Posts
Next >>